0001209191-20-050143.txt : 20200911 0001209191-20-050143.hdr.sgml : 20200911 20200911161625 ACCESSION NUMBER: 0001209191-20-050143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WU JINN CENTRAL INDEX KEY: 0001314254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 201171113 MAIL ADDRESS: STREET 1: 107 MORGAN LANE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001300699 Athenex, Inc. ATNX 0001314254 WU JINN C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Common Stock 2020-09-10 4 P 0 20000 11.15 A 391208 D Stock Option (Right to Buy) 4.55 2013-01-02 2023-01-02 Common Stock 40000 40000 D Stock Option (Right to Buy) 4.55 2014-02-12 2024-02-12 Common Stock 10000 10000 D Stock Option (Right to Buy) 5.50 2015-02-05 2025-02-05 Common Stock 54000 54000 D Stock Option (Right to Buy) 5.50 2017-03-20 2025-03-20 Common Stock 96000 96000 D Stock Option (Right to Buy) 11.00 2027-06-13 Common Stock 28500 28500 D Stock Option (Right to Buy) 17.30 2028-03-27 Common Stock 16500 16500 D Stock Option (Right to Buy) 13.17 2029-02-28 Common Stock 15000 15000 D Stock Option (Right to Buy) 12.45 2030-06-05 Common Stock 12500 12500 D This option vests in four equal annual installments beginning on June 13, 2018. This option vests in four equal annual installments beginning on March 27, 2019. This option vests in four equal annual installments beginning on February 28, 2020. This option vests in four equal annual installments beginning on June 5, 2021. /s/ Teresa Bair, Attorney-in-Fact 2020-09-11